Fortress Biotech
FBIO
#10157
Rank
S$82.9 M
Marketcap
S$2.49
Share price
0.52%
Change (1 day)
-21.75%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): S$0.18 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are S$68.46 Million. In 2025 the company made an earning of -S$43.19 Million, an increase over its 2024 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.18 B-533.92%
2025 -S$43.19 Million-72.02%
2024 -S$0.16 Billion-21.6%
2023 -S$0.2 Billion-28.03%
2022 -S$0.28 Billion29.88%
2021 -S$0.22 Billion59.8%
2020 -S$0.14 Billion1.17%
2019 -S$0.14 Billion-19.84%
2018 -S$0.17 Billion28.99%
2017 -S$0.13 Billion37.92%
2016 -S$91.35 Million32.31%
2015 -S$69.04 Million164.31%
2014 -S$26.13 Million-45.14%
2013 -S$47.61 Million37.55%
2012 -S$34.62 Million-22.91%
2011 -S$44.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
S$0.14 B-20.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-180.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-S$43.6 Million-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-S$43.43 Million-123.23%๐Ÿ‡บ๐Ÿ‡ธ USA